The last 20 actions on file set price targets from $32.00 to $50.00, averaging $38.56.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 1 Oct 2026 | Needham | BUY | $50.00 |
| 1 Oct 2026 | D.A. Davidson | BUY | $40.00 |
| 1 Oct 2026 | Barclays | BUY | $38.00 |
| 30 Sep 2026 | Cantor Fitzgerald | BUY | $38.00 |
| 30 Sep 2026 | William Blair | BUY | – |
| 29 Sep 2026 | CCORF | BUY | $37.00 |
| 14 Sep 2026 | Goldman Sachs | BUY | $38.00 |
| 10 Sep 2026 | Barclays | BUY | $38.00 |
| 9 Sep 2026 | Cantor Fitzgerald | BUY | $38.00 |
| 9 Sep 2026 | CCORF | BUY | $37.00 |
| 9 Sep 2026 | Wells Fargo | BUY | $45.00 |
| 9 Sep 2026 | William Blair | BUY | – |
| 9 Sep 2026 | UBS | BUY | $32.00 |
| 9 Sep 2026 | Raymond James | BUY | $33.00 |
| 9 Sep 2026 | BTIG | BUY | $35.00 |
| 9 Sep 2026 | Stephens | BUY | $34.00 |
| 9 Sep 2026 | Stifel | BUY | $35.00 |
| 9 Sep 2026 | Needham | BUY | $50.00 |
| 9 Sep 2026 | D.A. Davidson | BUY | $40.00 |
| 9 Sep 2026 | Oppenheimer | BUY | $36.00 |
No comments yet — be the first to weigh in on BRZE.